JP2012509295A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012509295A5 JP2012509295A5 JP2011536843A JP2011536843A JP2012509295A5 JP 2012509295 A5 JP2012509295 A5 JP 2012509295A5 JP 2011536843 A JP2011536843 A JP 2011536843A JP 2011536843 A JP2011536843 A JP 2011536843A JP 2012509295 A5 JP2012509295 A5 JP 2012509295A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- amyloid
- seq
- binds
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008037564.0 | 2008-11-19 | ||
| DE102008037564A DE102008037564A1 (de) | 2008-11-19 | 2008-11-19 | Zusammensetzung zur Herstellung von anti-Amyloid beta-Peptid-Antikörpern mit D-Peptiden |
| PCT/EP2009/065308 WO2010057882A2 (de) | 2008-11-19 | 2009-11-17 | Zusammensetzung zur herstellung von anti-amyloid beta-peptid-antikörpern mit d-peptiden |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012509295A JP2012509295A (ja) | 2012-04-19 |
| JP2012509295A5 true JP2012509295A5 (enExample) | 2013-01-17 |
| JP6029280B2 JP6029280B2 (ja) | 2016-11-24 |
Family
ID=41572521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011536843A Expired - Fee Related JP6029280B2 (ja) | 2008-11-19 | 2009-11-17 | Ｄ−ペプチドを有する抗−アミロイドβ−ペプチド抗体を製造するための組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9051364B2 (enExample) |
| EP (1) | EP2356144B1 (enExample) |
| JP (1) | JP6029280B2 (enExample) |
| CN (1) | CN102224168B (enExample) |
| DE (1) | DE102008037564A1 (enExample) |
| WO (1) | WO2010057882A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102010017130B4 (de) * | 2010-05-28 | 2018-11-29 | Forschungszentrum Jülich GmbH | Hybrid-Verbindung, deren Verwendung und Verfahren zu deren Herstellung |
| HRP20220519T1 (hr) | 2011-06-24 | 2022-05-27 | Nono Inc. | Kombinacijska terapija ishemije |
| US9241970B2 (en) * | 2011-12-13 | 2016-01-26 | Nono Inc. | Therapy for subarachnoid hemorrhage and ischemia |
| JP2015518474A (ja) * | 2012-04-05 | 2015-07-02 | フォルシュングスツェントルム ユーリッヒ ゲゼルシャフト ミット ベシュレンクテル ハフツングＦｏｒｓｃｈｕｎｇｓｚｅｎｔｒｕｍ Ｊｕｅｌｉｃｈ ＧｍｂＨ | 血液、血液生産物及び器官を処置する方法 |
| CN104380111B (zh) * | 2012-04-05 | 2017-08-29 | 于利希研究中心有限公司 | 包含多价结合淀粉样β蛋白的D‑肽的聚合物及其应用 |
| DE102012108598A1 (de) * | 2012-09-14 | 2014-04-10 | Forschungszentrum Jülich GmbH | Neue, von D3 abgeleitete D-enantiomere Peptide und deren Verwendung |
| DE102012102998B4 (de) * | 2012-04-05 | 2013-12-05 | Forschungszentrum Jülich GmbH | Polymere, enthaltend multivalente Amyloid-Beta-bindende D-Peptide und deren Verwendung |
| DE102014003262A1 (de) | 2014-03-12 | 2015-09-17 | Forschungszentrum Jülich GmbH | Amyloid-Beta-bindende Peptide und deren Verwendung für die Therapie und die Diagnose der Alzheimerschen Demenz |
| DE102013016002A1 (de) | 2013-09-26 | 2015-03-26 | Forschungszentrum Jülich GmbH | Zyklische, Amyloid-Beta-bindende Peptide und deren Verwendung |
| US10995118B2 (en) | 2013-09-26 | 2021-05-04 | Forschungszentrum Juelich Gmbh | Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosis of alzheimer's disease |
| DE102015003676A1 (de) * | 2015-03-20 | 2016-09-22 | Forschungszentrum Jülich GmbH Fachbereich Patente | Spezifisch A-Beta Spezies bindende Peptide für die Therapie und/oder die Diagnose der Alzheimerschen Demenz |
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| KR20210124308A (ko) | 2019-01-30 | 2021-10-14 | 트루바인딩 아이엔씨. | 항-gal3 항체 및 이의 용도 |
| MX2022014786A (es) | 2020-05-26 | 2023-01-16 | Truebinding Inc | Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3. |
| TW202300517A (zh) | 2021-03-12 | 2023-01-01 | 美商美國禮來大藥廠 | 抗類澱粉β抗體及其用途 |
| WO2022251048A1 (en) | 2021-05-24 | 2022-12-01 | Eli Lilly And Company | Anti-amyloid beta antibodies and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR950702839A (ko) * | 1992-08-27 | 1995-08-23 | 스티븐 딕 | 레트로, 인버소-, 및 레트로- 인버소 합성 펩티드 유사체(retro-, inverso-, and retro-inverso synthetic peptide analogues) |
| US6277826B1 (en) * | 1996-08-27 | 2001-08-21 | Praecis Pharmaceuticals, Inc. | Modulators of β-amyloid peptide aggregation comprising D-amino acids |
| NZ514414A (en) | 1999-03-04 | 2004-02-27 | Praecis Pharm Inc | Modulators of beta-amyloid peptide aggregation comprising D-amino acids |
| US6849714B1 (en) * | 1999-05-17 | 2005-02-01 | Conjuchem, Inc. | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| DE10117281A1 (de) * | 2001-04-06 | 2002-10-24 | Inst Molekulare Biotechnologie | Peptid zur Diagnose und Therapie der Alzheimer-Demenz |
| US6906169B2 (en) * | 2001-05-25 | 2005-06-14 | United Biomedical, Inc. | Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide |
| US20050026165A1 (en) * | 2001-05-31 | 2005-02-03 | Cindy Orser | Detection of conformationally altered proteins and prions |
| SI2336147T1 (sl) * | 2003-12-17 | 2014-08-29 | Janssen Alzheimer Immunotherapy | Konjugati nosilcev a beta imunogenih peptidov in postopki izdelave istih |
-
2008
- 2008-11-19 DE DE102008037564A patent/DE102008037564A1/de not_active Withdrawn
-
2009
- 2009-11-17 WO PCT/EP2009/065308 patent/WO2010057882A2/de not_active Ceased
- 2009-11-17 JP JP2011536843A patent/JP6029280B2/ja not_active Expired - Fee Related
- 2009-11-17 US US13/129,579 patent/US9051364B2/en not_active Expired - Fee Related
- 2009-11-17 EP EP09774854.5A patent/EP2356144B1/de not_active Not-in-force
- 2009-11-17 CN CN200980146026.4A patent/CN102224168B/zh not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sangesland et al. | Allelic polymorphism controls autoreactivity and vaccine elicitation of human broadly neutralizing antibodies against influenza virus | |
| US10000556B2 (en) | Single-domain VHH antibodies directed to norovirus GI.1 and GII.4 and their use | |
| JP2010514805A5 (enExample) | ||
| CN102224168B (zh) | 用于生产抗淀粉状蛋白β肽抗体的含有D-肽的组合物 | |
| JP2014523742A5 (enExample) | ||
| JP2011528561A5 (enExample) | ||
| JP2023525518A (ja) | 新規アンキリンリピート結合タンパク質とその用途 | |
| JP2009240315A5 (enExample) | ||
| JP2013524774A5 (enExample) | ||
| RU2013106270A (ru) | Моноклональное антитело против addl и его применения | |
| CN102498217A (zh) | Hpv的e6蛋白的特异性抗体及其应用 | |
| JP2005531286A (ja) | ＨＣＶＥ２グリコプロテインに対して向けられ、ｉｎｖｉｔｒｏ中和活性を有するヒトモノクローナル抗体Ｆａｂ断片 | |
| JP2013505938A5 (enExample) | ||
| RU2022108606A (ru) | Антитела к фактору ix padua | |
| AU2022239051A1 (en) | Pharmaceutical composition for ameliorating acute lung injury and acute worsening of pulmonary fibrosis | |
| EP3992205A1 (en) | Sars coronavirus-2 spike protein binding compounds | |
| JP2012523221A5 (enExample) | ||
| CN103833830B (zh) | 柯萨奇病毒a16型的保守中和表位多肽及其用途 | |
| JP2018529630A (ja) | 自閉症を診断および治療するための抗原性ペプチドおよびその使用 | |
| JP2008515388A5 (enExample) | ||
| CN114671947B (zh) | 乙肝病毒不同亚型表面s蛋白高亲和力纳米抗体及其应用 | |
| JP2009525741A5 (ja) | HERV−W干渉群に属するウィルスの包膜とhASCT受容体との間の相互作用に必要なペプチド領域からなるペプチド | |
| RU2014102721A (ru) | Способ получения агента, связывающегося с препро-вазопрессином или с его фрагментами | |
| JP2023145633A5 (enExample) | ||
| JP2008522632A5 (enExample) |